94 related articles for article (PubMed ID: 8575537)
1. Binding of distamycin and chromomycin to human immunodeficiency type 1 virus DNA: a non-radioactive automated footprinting study.
Feriotto G; Mischiati C; Bianchi N; Passadore M; Gambari R
Eur J Pharmacol; 1995 Jul; 290(2):85-93. PubMed ID: 8575537
[TBL] [Abstract][Full Text] [Related]
2. Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Disruption of nuclear factor.DNA complexes and inhibition of in vitro transcription.
Bianchi N; Passadore M; Rutigliano C; Feriotto G; Mischiati C; Gambari R
Biochem Pharmacol; 1996 Nov; 52(10):1489-98. PubMed ID: 8937462
[TBL] [Abstract][Full Text] [Related]
3. Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions.
Passadore M; Feriotto G; Bianchi N; Aguiari G; Mischiati C; Piva R; Gambari R
J Biochem Biophys Methods; 1994 Dec; 29(3-4):307-19. PubMed ID: 7699207
[TBL] [Abstract][Full Text] [Related]
4. Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNAase I footprinting study.
Feriotto G; Mischiati C; Gambari R
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):451-8. PubMed ID: 8172606
[TBL] [Abstract][Full Text] [Related]
5. Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs.
Gambari R; Feriotto G; Rutigliano C; Bianchi N; Mischiati C
J Pharmacol Exp Ther; 2000 Jul; 294(1):370-7. PubMed ID: 10871335
[TBL] [Abstract][Full Text] [Related]
6. Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.
Bianchi N; Rutigliano C; Passadore M; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):919-27. PubMed ID: 9307046
[TBL] [Abstract][Full Text] [Related]
7. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Fesen M; Pommier Y
J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
[TBL] [Abstract][Full Text] [Related]
8. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
Bell A; Kittler L; Löber G; Zimmer C
J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648
[TBL] [Abstract][Full Text] [Related]
9. Interaction of lambda cro repressor with synthetic operator OR3 studied by competition binding with minor groove binders.
Gursky GV; Surovaya AN; Kurochkin AV; Chernov BK; Volkov SK; Kirpichnikov MP
J Biomol Struct Dyn; 1992 Aug; 10(1):15-33. PubMed ID: 1329842
[TBL] [Abstract][Full Text] [Related]
10. [Specific protection of DNA by distamycin A, netropsin and bis-netropsins against the action of DNAse I].
Skamrov AV; Rybalkin IN; Bibilashvili RSh; Gottikh BP; Grokhovskiĭ SL
Mol Biol (Mosk); 1985; 19(1):177-95. PubMed ID: 2984546
[TBL] [Abstract][Full Text] [Related]
11. DNA sequence recognition by bis-linked netropsin and distamycin derivatives.
Grokhovsky SL; Surovaya AN; Burckhardt G; Pismensky VF; Chernov BK; Zimmer C; Gursky GV
FEBS Lett; 1998 Nov; 439(3):346-50. PubMed ID: 9845351
[TBL] [Abstract][Full Text] [Related]
12. A nonradioactive automated protocol to study protein-DNA interactions by dnase-I footprinting.
Mischiati C; Feriotto G; Bianchi N; Gambari R
Int J Oncol; 1995 Jan; 6(1):153-6. PubMed ID: 21556516
[TBL] [Abstract][Full Text] [Related]
13. Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues.
Feriotto G; Ciucci A; Mischiati C; Animati F; Lombardi P; Giacomini P; Arcamone F; Gambari R
Eur J Pharmacol; 1994 Apr; 267(2):143-9. PubMed ID: 8050475
[TBL] [Abstract][Full Text] [Related]
14. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
Yamamoto K; Sugiyama H; Kawanishi S
Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
[TBL] [Abstract][Full Text] [Related]
15. Identification of preferred distamycin-DNA binding sites by the combinatorial method REPSA.
Hardenbol P; Wang JC; Van Dyke MW
Bioconjug Chem; 1997; 8(5):617-20. PubMed ID: 9327123
[TBL] [Abstract][Full Text] [Related]
16. Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements.
Broggini M; Ponti M; Ottolenghi S; D'Incalci M; Mongelli N; Mantovani R
Nucleic Acids Res; 1989 Feb; 17(3):1051-9. PubMed ID: 2922260
[TBL] [Abstract][Full Text] [Related]
17. Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin.
Rutigliano C; Bianchi N; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Int J Oncol; 1998 Feb; 12(2):337-43. PubMed ID: 9458359
[TBL] [Abstract][Full Text] [Related]
18. Allosteric interaction of minor groove binding ligands with UL9-DNA complexes.
Kwok Y; Zhang W; Schroth GP; Liang CH; Alexi N; Bruice TW
Biochemistry; 2001 Oct; 40(42):12628-38. PubMed ID: 11601987
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
20. Methidiumpropyl-EDTA.Fe(II) and DNase I footprinting report different small molecule binding site sizes on DNA.
Van Dyke MW; Dervan PB
Nucleic Acids Res; 1983 Aug; 11(16):5555-67. PubMed ID: 6225070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
